Dr. Creager Joins Seraph’s Board of Directors
Source: Seraph Biosciences, Inc.
Dr. Creager Joins Seraph’s Board of Directors DETROIT, June 11, 2021 – Dr. Richard S. Creager, an established executive and consultant in the In Vitro […]
Dr. Ishaque Joins Seraph’s Board of Directors
Source: Seraph Biosciences, Inc.
Dr. Ishaque Joins Seraph’s Board of Directors DETROIT, May 3, 2021 – Dr. Nadeem Ishaque, former Chief Innovation Officer of GE Healthcare, joined Seraph’s Board […]
Seraph Biosciences selected by NIH as RADx Participant in the War Against COVID-19
Source: Seraph Biosciences, Inc.
Seraph Biosciences selected by NIH as RADx Participant in the War Against COVID-19 During the World War II era, MIT’s “Rad Lab” gave birth to […]
Seraph Vice President Gives Featured Interview with George Mason University
Source: George Mason University
Seraph Vice President Gives Featured Interview with George Mason University This month Shane Trexler, Seraph’s Vice President of Engineering and an alumnus of George Mason […]
Seraph Awarded Diagnostic Development Initiative Grant
Source: Seraph Biosciences, Inc.
Seraph Awarded Diagnostic Development Initiative Grant (DETROIT) – Seraph Biosciences, Inc. (“Seraph”), creator of Seraspec®, was recently awarded promotional credits from Amazon Web Services (“AWS”) […]
Seraph Names Fouad Sayegh as Product VP
Source: Seraph Biosciences, Inc.
Seraph Names Fouad Sayegh as Product VP DETROIT, February 21, 2020 – Seraph Biosciences, Inc., creator of Seraspec®, is pleased to welcome Mr. Fouad Sayegh […]
BioIntelligence Revolution
Source: TEDxWayneStateU
TEDx Unveils “The BioIntelligence Revolution” The TEDx program has officially released Seraph Chairman, Dr. Charles Shanley’s second TEDx talk on the “BioIntelligence Revolution”. The talk […]
Seraph Closes $4.2 Million Series B
Source: Seraph Biosciences, Inc.
Seraph Closes $4.2 Million Series B Round DETROIT, April 28, 2019 – Seraph Biosciences, Inc., creator of Seraspec®, is pleased to announced that it […]
Dr. Loveman Joins Seraph’s Board
Source: Seraph Biosciences, Inc.
Dr. Gary Loveman Joins Seraph’s Board DETROIT, Feb. 19, 2019 – Seraph Biosciences, Inc., creator of Seraspec®, is pleased to announced that Dr. Gary Loveman, […]
Seraph Signs Deal with Zomedica
Source: Crain's Detroit Business
Seraph Biosciences signs deal with Zomedica on pathogen identifier device Seraph Biosciences Inc., a Detroit-based biomedical device company based at Wayne State University, has […]